Halozyme Therapeutics, Inc.
HALO
$38.57
$0.110.29%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 336.00M | 483.28M | 348.28M | 275.61M | 362.79M |
| Total Receivables | 234.21M | 217.33M | 246.18M | 194.88M | 231.07M |
| Inventory | 127.60M | 128.92M | 132.41M | 107.52M | 100.12M |
| Prepaid Expenses | 48.61M | 49.48M | 38.89M | 37.01M | 45.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 746.42M | 879.01M | 765.75M | 615.02M | 739.01M |
|
|
|||||
| Total Current Assets | 746.42M | 879.01M | 765.75M | 615.02M | 739.01M |
| Net Property, Plant & Equipment | 74.94M | 74.67M | 74.56M | 77.96M | 75.57M |
| Long-term Investments | 416.82M | 416.82M | 416.82M | 416.22M | 409.05M |
| Goodwill | 416.82M | 416.82M | 416.82M | 416.22M | 409.05M |
| Total Other Intangibles | 472.88M | 490.64M | 510.98M | 528.82M | 546.65M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.20M | 31.53M | 42.33M | 61.42M | 71.23M |
| Total Assets | 1.73B | 1.89B | 1.81B | 1.70B | 1.84B |
|
|
|||||
| Total Accounts Payable | 11.82M | 19.32M | 10.12M | 8.70M | 17.69M |
| Total Accrued Expenses | 94.10M | 36.78M | 54.92M | 43.24M | 97.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.58M | 3.94M | 2.72M | 4.49M | 15.44M |
| Total Finance Division Other Current Liabilities | -- | 55.15M | 48.64M | 35.49M | -- |
| Total Other Current Liabilities | -- | 55.15M | 48.64M | 35.49M | -- |
| Total Current Liabilities | 112.49M | 115.19M | 116.39M | 91.92M | 130.79M |
|
|
|||||
| Total Current Liabilities | 112.49M | 115.19M | 116.39M | 91.92M | 130.79M |
| Long-Term Debt | 1.50B | 1.50B | 1.50B | 1.49B | 1.49B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.62M | 28.42M | 30.88M | 29.57M | 32.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.10M | 2.25M | 16.14M | 17.73M | 15.47M |
| Total Liabilities | 1.65B | 1.64B | 1.66B | 1.63B | 1.67B |
|
|
|||||
| Common Stock & APIC | 2.54M | 25.67M | 12.20M | 132.00K | 27.50M |
| Retained Earnings | 90.55M | 222.29M | 140.45M | 65.69M | 143.22M |
| Treasury Stock & Other | -9.28M | 1.23M | -1.62M | 24.00K | -922.00K |
| Total Common Equity | 83.81M | 249.18M | 151.03M | 65.85M | 169.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 83.81M | 249.18M | 151.03M | 65.85M | 169.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 83.81M | 249.18M | 151.03M | 65.85M | 169.80M |
|
|
|||||
